from FOX News https://ift.tt/2MsgAHC
FDA extends review process for Novartis drug by three months
The review process for a drug to treat patients with relapsing multiple sclerosis was extended by three months.
from FOX News https://ift.tt/2MsgAHC
from FOX News https://ift.tt/2MsgAHC
0 comments:
Post a Comment